Skip to main content
SpringerLink
Log in

The effect of prolactin and bromocriptine on human peripheral immune status

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The aim of this study was to determine the influence of elevated serum prolactin (PRL) levels on the peripheral lymphocyte subsets in patients with hyperprolactinemia. For this purpose we studied 20 hyperprolactinemic patient lymphocyte subsets by flow cytometry on their hyperprolactinemic state and after their serum prolactin concentration was normalized with bromocriptine (BC) alone or BC and surgery. We observed decreased absolute numbers and percentage of Natural Killer (p=0.0009 and 0.0001, respectively) and CD3/CD25 lymphocytes (p= 0.009 and 0.002) in hyperprolactinemic patients, compared to 8 sex- and age-matched normal controls. There was no correlation between PRL levels and CD16/56 and CD3/CD25 numbers (p=0.72 and 0.33, respectively). We did not find any significant difference in absolute numbers (p=0.95) and percentage (p=0.84) of B-lymphocytes of hyperprolactinemic patients, as compared with normal controls. We did not detect any increase in absolute cell numbers of CD16/CD56 (p=0.21) and CD3/CD25 (p=0.61) of BC-treated patients when compared to their hyperprolactinemic state. We demonstrated an increase in CD8-cells (p=0.0173) and a decrease in CD4/CD8 ratio (p=0.036) in hyperprolactinemic patients treated with BC. There was also an increase in the number of activated T-cells (CD3/HLA DR) in this group, compared to normal controls and the hyperprolactinemic state of the same patients (p=0.04). In conclusion, elevated PRL levels do not lead to an “overstimulation” of the B-cells, but deteriorate the cytotoxic function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cooke N.E. Prolactin: Basic physiology. In: DeGroot L.J. (Eds), Endocrinology. Saunders, Philadelphia, 1995, vol. 1, p. 368.

    Google Scholar 

  2. Gerli R., Rambotti P., Nicoletti I., Orlandi S., Migliorati G., Riccardi C. Reduced number of natural killer cells in patients with pathological hyperprolactinemia. Clin. Exp. Immunol. 1986, 64: 399–406.

    CAS  PubMed Central  PubMed  Google Scholar 

  3. Matera L., Ciccarelli E., Cesano A., Veglia F., Miola C., Camanni F. Natural killer activity in hyperprolactinemic patients. Immunopharmacology 1989, 18: 143–146.

    Article  CAS  PubMed  Google Scholar 

  4. Cross R.J., Campbell J.L., Roszman T.L. Potentation of antibody responsiveness after the transplantation of a syngeneic pituitary gland. J. Neuroimmunol. 1989, 25: 29–35.

    Article  CAS  PubMed  Google Scholar 

  5. Dineen J.K., Kelly J.D. The suppression of rejection of nippostrongylus brasiliensis in lacting rats: the nature of immunologic defect. Immunology 1972, 22: 1–12.

    CAS  PubMed Central  PubMed  Google Scholar 

  6. Kelly J.D., Dineen J.K. The suppression of rejection of nippostrongylus brasiliensis in Lewis strain rats treated with ovine prolactin. Immunology 1973, 24: 551–558.

    CAS  PubMed Central  PubMed  Google Scholar 

  7. McMurray R., Keisler D., Kanuckel K., Izui S., Walker S.E. Prolactin influences autoimmune disease activity in the female B/W mouse. J. Immunology 1991, 147: 3780–3787.

    CAS  Google Scholar 

  8. Palestine A.G., Muellenberg-Coulombre C.G., Kim M.K., Gelato M.C., Nussenblatt R.B. Bromocriptine and lowe dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat. J. Clin. Invest. 1987, 79: 1078–1081.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Whyte A., Williams R.O. Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum. 1988, 31: 927–928.

    Article  CAS  PubMed  Google Scholar 

  10. Reber P.M. Prolactin and immunomodulation. Am. J. Med. 1993, 95: 637–644.

    Article  CAS  PubMed  Google Scholar 

  11. Mukherjee P., Mastro A.M., Hymer W.C. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 1990, 126: 88–94.

    Article  CAS  PubMed  Google Scholar 

  12. Koller M., Kotzmann H., Clodi M., Riedl M., Luger A. Effect of elevated serum prolactin concentrations on the immunophenotype of human lymphocytes, mitogen-induced proliferation and phagocytic activity of polymorphonuclear cells. Eur. J. Clin. Invest. 1997, 27: 662–666.

    Article  CAS  PubMed  Google Scholar 

  13. Vidaller A., Llorente L., Larrea F., Mendez J.P., Alcocer-Varela J., Alarcon-Segovia D. T-cell dysregulation in patients with hyperprolactinemia: Effect of bromocriptine treatment. Clin. Immunol. Immunopathol. 1986, 38: 337–343.

    Article  CAS  PubMed  Google Scholar 

  14. Honorati M.C., Travaglini P., De Bernardi B., Scorza R., Hu C., Togni M.E., Radelli L., Vanoli M., Zanussi C. NK activity in patients with pathological hyperprolactinemia: effect of bromocriptine. Int. J. Neurosci. 1990, 51: 303–305.

    Article  CAS  PubMed  Google Scholar 

  15. Morikawa K., Oseko F., Morikawa S. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin. Exp. Immunol. 1994, 95: 514–518.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Endocrinology, University of Istanbul, Istanbul, Turkey, Fulya cad. Inci ap. 27/30, 81620

    P. Kadioglu, O. Açbay & S. Gundogdu

  2. Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Oncology, University of Istanbul, Istanbul, Turkey

    G. Demir

  3. Department of Neurosurgery, Istanbul, Turkey

    N. Gazioglu

Authors
  1. P. Kadioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Açbay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Demir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Gazioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Gundogdu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Kadioglu.

Additional information

Supported by the Research Fund of The University of Istanbul. Project no. 843/190496.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kadioglu, P., Açbay, O., Demir, G. et al. The effect of prolactin and bromocriptine on human peripheral immune status. J Endocrinol Invest 24, 147–151 (2001). https://doi.org/10.1007/BF03343834

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343834

Key-words

Search

Navigation